Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991007176) METHOD AND COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISORDERS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/007176 International Application No.: PCT/US1990/006697
Publication Date: 30.05.1991 International Filing Date: 15.11.1990
Chapter 2 Demand Filed: 04.06.1991
IPC:
A61K 31/19 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
Applicants:
BREUER, Richard, I. [US/US]; US
Inventors:
BREUER, Richard, I.; US
Agent:
KATZ, Martin, L.; Dressler, Goldsmith, Shore, Sutker & Milnamow, Ltd. Two Prudential Plaza, Suite 4700 Chicago, IL 60601 , US
Priority Data:
438,29716.11.1989US
Title (EN) METHOD AND COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISORDERS
(FR) PROCEDE ET COMPOSITION DE TRAITEMENT DE TROUBLES INFLAMMATOIRES DES INTESTINS
Abstract:
(EN) A method for the treatment of inflammatory bowel disorders, together with a pharmaceutical composition comprising short chain fatty acids that is useful therein, is described in this invention. The administration of short chain fatty acids of about 2 to about 6 carbon-length to patients afflicted with inflammatory bowel disorders is shown to effectively alleviate the symptoms of the treated disorder.
(FR) Procédé de traitement de troubles inflammatoires des intestins et composition pharmaceutique contenant des acides gras à chaîne courte utilisée pour mettre en ÷uvre le procédé. On a démontré que l'administration d'acides gras à chaîne courte d'une longueur comprise entre 2 à 6 atomes de carbone environ à des patients souffrant de troubles inflammatoires des intestins soulage efficacement les symptômes du trouble soumis au traitement.
Designated States: CA, FI, JP, NO
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0502925CA2071215